NTRK1 and Miyoshi myopathy: Although the characterization of TrkA amplification in metastatic samples is missing and more detailed insights are required to understand the oncogenic potential of TrkA in normal melanocytes and MM cells with distinct molecular background, our observations identified a previously unknown association between TrkA function and MM development relying on TrkA amplification.